Efficacy and Tolerability of AP707 in Patients With Chronic Pain Due to Diabetic Polyneuropathy

Clinical trial NCT06072573 · UNKNOWN

Trial details

NCT number: NCT06072573
Sponsor: Apurano Pharmaceuticals GmbH
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Pain Pain Syndrome Pain, Chronic Chronic Pain Chronic Pain Syndrome Diabetes Diabetic Neuropathies Diabetic Polyneuropathy Peripheral Neuralgia Peripheral Neuropathy Peripheral Neuropathy With Type 2 Diabetis

Start date: 2023-11-02
Primary completion: 2024-09-30
Enrollment: 558

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.